Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788
- 14 March 1982
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 28 (3) , 287-290
- https://doi.org/10.1016/0304-3940(82)90072-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Benzodiazepine Antagonist Ro 15?1788: Binding Characteristics and Interaction with Drug-Induced Changes in Dopamine Turnover and Cerebellar cGMP LevelsJournal of Neurochemistry, 1982
- Reversal of the antiaversive and anticonvulsant actions of diazepam, but not of progabide, by a selective antagonist of benzodiazepine receptorsEuropean Journal of Pharmacology, 1981
- Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)European Journal of Pharmacology, 1981
- Differential cataleptogenic and antistereotypic effects of caerulein and haloperidolNeuropharmacology, 1981
- Selective antagonists of benzodiazepinesNature, 1981
- Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidolNeuropharmacology, 1981
- Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleepEuropean Journal of Pharmacology, 1980
- Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepamEuropean Journal of Pharmacology, 1980
- Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)Neuropharmacology, 1980
- Molecular Mechanisms in the Receptor Action of BenzodiazepinesAnnual Review of Pharmacology and Toxicology, 1979